Document Detail


Pulmonary ground-glass opacity (GGO) lesions-large size and a history of lung cancer are risk factors for growth.
MedLine Citation:
PMID:  18978558     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: Ground-glass opacity (GGO) of the lung is being frequently detected by thin section computed tomography scan. However, the long term management of detected GGO is still unclear. To establish follow-up plans, we performed the clinical and radiological review to identify the factors that are closely associated with GGO growth. METHODS: We retrospectively analyzed computed tomography images of 125 GGOs that were stable for 3 months between 1999 and 2006 at the Cancer Institute Hospital, Tokyo. To identify factors that affect the roentgenological growth, the time to GGO growth curve by Kaplan-Meyer method was evaluated in terms of gender, age, smoking, initial size, existence of a solid part, GGO density, location, multiplicity, and lung cancer history by univariate and multivariate analyses. RESULTS: The median observation period was 1048 days (177-3269) and 26 of 125 GGOs (21%) grew. The estimated growth population for 5 years was 30%. The growth was more frequently seen in the elderly (p = 0.017), in part-solid GGO (p < 0.01) and in GGO of larger than 10 mm (p < 0.01, logrank test). By multivariate analysis, initial size (p < 0.01, Cox's model) and history of lung cancer (p = 0.017, logistic model) were independent factors that were significantly associated with GGO growth. Fifty GGOs that were 10 mm or smaller and without a lung cancer history did not grow within 3.5 years. CONCLUSIONS: After initial management and 3 month follow-up, larger size (more than 10 mm) and a history of lung cancer are risk factors for GGO growth, and therefore should be considered when making a follow-up plan.
Authors:
Miyako Hiramatsu; Takuya Inagaki; Tomoya Inagaki; Yoshio Matsui; Yukitoshi Satoh; Sakae Okumura; Yuichi Ishikawa; Etsuo Miyaoka; Ken Nakagawa
Related Documents :
21569288 - Estrogen receptor positive breast cancers and their association with environmental fact...
21680538 - Cracking the estrogen receptor's posttranslational code in breast tumors.
11280768 - Regulation of growth and tumorigenicity of breast cancer cells by the low molecular wei...
9279518 - Increased circulating levels of insulin-like growth factor-i and decreased circulating ...
17239268 - Primary squamous cell carcinoma of the breast: value of positron emission tomography sc...
22851048 - Cost comparison of radiation treatment options after lumpectomy for breast cancer.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer     Volume:  3     ISSN:  1556-1380     ISO Abbreviation:  J Thorac Oncol     Publication Date:  2008 Nov 
Date Detail:
Created Date:  2008-11-03     Completed Date:  2009-01-29     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101274235     Medline TA:  J Thorac Oncol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1245-50     Citation Subset:  IM    
Affiliation:
Department of Thoracic Surgical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Koto-ku, Tokyo, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Aged, 80 and over
Female
Humans
Lung / pathology*
Lung Neoplasms / pathology*,  radiography
Male
Middle Aged
Prognosis
Retrospective Studies
Risk Factors
Tomography, X-Ray Computed

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  AZGP1 autoantibody predicts survival and histone deacetylase inhibitors increase expression in lung ...
Next Document:  Diagnostic and prognostic implications of pleural adhesions in malignant effusions.